En este marco, la compaa ha implementado un sistema de Farmacovigilancia que permite reportar de forma temprana posibles reacciones adversas a los medicamentos, contribuyendo as al uso racional y seguro de los tratamientos
placebo, 80.4% (41/51)), and mean age (s.d.) was similar (apitegromab, 44.2 years (11.0)
Cardiovascular Outcomes with Semaglutide: The SUSTAIN-6 trial (Marso et al., 2016, New England Journal of Medicine ) revealed that semaglutide significantly reduced the risk of major adverse cardiovascular events, highlighting its benefits beyond glucose control
Bacteriostatic water for injection allows the administration of medications through different parenteral (outside the gut) routes , such as intravenous (into the veins), intramuscular (into the muscles), and subcutaneous (under the skin) routes
12 Therapeutic GLP-1 receptor agonism has been associated with delayed gastric emptying, which aids in weight loss by reducing appetite, increasing satiety, and reducing energy intake